- Home
- SNDX vs BTBT Comparison
SNDX vs BTBT Comparison
Compare SNDX & BTBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDX
- BTBT
- Stock Information
- Founded
- SNDX 2005
- BTBT 2015
- Country
- SNDX United States
- BTBT United States
- Employees
- SNDX N/A
- BTBT N/A
- Industry
- SNDX Biotechnology: Pharmaceutical Preparations
- BTBT Finance: Consumer Services
- Sector
- SNDX Health Care
- BTBT Finance
- Exchange
- SNDX Nasdaq
- BTBT Nasdaq
- Market Cap
- SNDX 1.1B
- BTBT 1.1B
- IPO Year
- SNDX 2016
- BTBT 2018
- Fundamental
- Price
- SNDX $14.75
- BTBT $3.03
- Analyst Decision
- SNDX Strong Buy
- BTBT Strong Buy
- Analyst Count
- SNDX 10
- BTBT 3
- Target Price
- SNDX $38.40
- BTBT $6.33
- AVG Volume (30 Days)
- SNDX 2.0M
- BTBT 21.1M
- Earning Date
- SNDX 11-04-2025
- BTBT 11-17-2025
- Dividend Yield
- SNDX N/A
- BTBT N/A
- EPS Growth
- SNDX N/A
- BTBT N/A
- EPS
- SNDX N/A
- BTBT N/A
- Revenue
- SNDX $77,933,000.00
- BTBT $98,402,256.00
- Revenue This Year
- SNDX $585.73
- BTBT $13.37
- Revenue Next Year
- SNDX $94.17
- BTBT $55.59
- P/E Ratio
- SNDX N/A
- BTBT N/A
- Revenue Growth
- SNDX 2126.66
- BTBT 13.30
- 52 Week Low
- SNDX $8.58
- BTBT $1.69
- 52 Week High
- SNDX $22.50
- BTBT $5.74
- Technical
- Relative Strength Index (RSI)
- SNDX 47.48
- BTBT 57.98
- Support Level
- SNDX $15.71
- BTBT $2.86
- Resistance Level
- SNDX $16.50
- BTBT $3.16
- Average True Range (ATR)
- SNDX 0.81
- BTBT 0.18
- MACD
- SNDX -0.36
- BTBT 0.05
- Stochastic Oscillator
- SNDX 2.73
- BTBT 82.99
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.
About BTBT Bit Digital Inc.
Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.